P. Baumgaertner

Discipline

Histoire, Philosophie et Sociologie des sciences (4) Economies et finances (1)

Type de document

Articles (37) Recensions (1)

Co-auteur

Date

Source

Mot-clé

Patients (25) Patients (25) Melanoma (24) T cells (21) Human beings (20) Cells (20) Cancer (19) cancer (17) Cancer (17) Vaccination (15) Vaccination (15) Antigens (11) Receptors (11) Tumors (10) Expression (10) analyse (9) Analysis (9) Tumors (9) roman (9) Development (8) Treatment (8) Identification (8) Vaccines (8) Peptides (8) Identification (8) Flow cytometry (8) Blood (8) Identification (8) spectacle (7) différenciation (7)

Documents écrit par P. Baumgaertner (37) | parle de P. Baumgaertner (0)

CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity.
P. Baumgaertner et al. (10 août 2022)
Sensitive identification of neoantigens and cognate TCRs in human solid tumors.
M. Arnaud et al.
A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma.
A. Harari et al. (18 nov. 2021)
Inflammatory B cells correlate with failure to checkpoint blockade in melanoma patients.
K. de Jonge et al. (2 févr. 2021)
Unsupervised Analysis of Flow Cytometry Data in a Clinical Setting Captures Cell Diversity and Allows Population Discovery.
P. Baumgaertner et al. (2021)
Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival.
F. Berner et al. (2021)
Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines.
M. Graciotti et al. (2 juin 2020)
Circulating CD56bright NK cells inversely correlate with survival of melanoma patients.
K. de Jonge et al. (14 mars 2019)
Low Avidity T Cells Do Not Hinder High Avidity T Cell Responses Against Melanoma
K. Ioannidou et al. (2019)
High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence.
L. Carretero-Iglesia et al. (2019)
The C-terminal extension landscape of naturally presented HLA-I ligands.
P. Guillaume et al. (15 mai 2018)
Lymphatic vessel density is associated with CD8+ T cell infiltration and immunosuppressive factors in human melanoma.
N. Bordry et al. (2018)
Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data.
J. Racle et al. (13 nov. 2017)
Rapid and Continued T-Cell Differentiation into Long-term Effector and Memory Stem Cells in Vaccinated Melanoma Patients.
P.O. Gannon et al. (1 juil. 2017)
Heterogeneity assessment of functional T cell avidity.
K. Ioannidou et al. (13 mars 2017)
A Well-Controlled Experimental System to Study Interactions of Cytotoxic T Lymphocytes with Tumor Cells.
N.J. Neubert et al.
Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8(+) and CD4(+) T-cell responses with multiple specificities including a novel DR7-restricted epitope.
P. Baumgaertner et al. (2016)
Vaccination with LAG-3Ig (IMP321) and peptides induces specific CD4 and CD8 T-cell responses in metastatic melanoma patients - report of a phase I/IIa clinical trial.
A. Legat et al. (2016)
Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients.
T. Murray et al. (2016)
Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR-Ligand Off-Rates Measurements on Living Cells.
M. Hebeisen et al. (2015)
Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab.
C. Meyer et al. (2014)
Prediction of cross-recognition of peptide-HLA A2 by Melan-A-specific cytotoxic T lymphocytes using three-dimensional quantitative structure-activity relationships.
T. Fagerberg et al. (2013)
SHP-1 phosphatase activity counteracts increased T cell receptor affinity.
M. Hebeisen et al. (2013)
Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells.
P. Baumgaertner et al. (2012)
Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization.
L. Baitsch et al. (2012)

next